Market Place
Sourcing Support
SwanBio Appointed Executive Chair and Chief Operating Officer
16 Oct 2023 //
BUSINESSWIRE
SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy
04 Oct 2023 //
BUSINESSWIRE
SwanBio Unveils Research in Next Generation CNS Capsids at ASGCT
18 May 2023 //
BUSINESSWIRE
SwanBio Therapeutics Confirms Substantial Burden of Disease of (AMN)
10 May 2023 //
BUSINESSWIRE
SwanBio Therapeutics initiates Phase I/II trial of gene therapy for AMN
16 Dec 2022 //
CLINICALTRIALSARENA
SwanBio Therapeutics Initiates First-in-Human Study of AAV Gene Therapy
15 Dec 2022 //
BUSINESSWIRE
Purespring and SwanBio announce licensing agreement for use of FunSel screening
18 Jul 2022 //
GLOBENEWSWIRE
SwanBio Presents Design of Innovative Natural History Study
27 Jun 2022 //
BUSINESSWIRE
SwanBio leans heavily on Syncona to close $56M series B
18 May 2022 //
FIERCEBIOTECH
SwanBio Therapeutics Announces $56M Series B Financing
18 May 2022 //
BUSINESSWIRE
FDA Clears SwanBio`s IND for AAV-Based Gene Therapy for Adrenomyeloneuropathy
25 Jan 2022 //
BUSINESSWIRE
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
01 Jun 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.